摘要
目的探讨三维适形放疗(3DCRT)非小细胞肺癌(NSCLC)患者的疗效和副作用。方法112例III期NSCLC患者随机分为三维适形放疗组(治疗组)和常规放疗组(常规组)各56例。治疗组予3DCRT照射,隔日1次,每次4—8Gy,总照射量40-64Gy;常规组予常规分割照射,每周治疗5次,每次1.8~2.0Gy,总照射量60。70Gy。结果3DCRT组有效率67.8%(CR+PR),完全缓解率32.1%(CR);常规组有效率28.6%,完全缓解率3.6%(P〈0.05)。3DRCT组1年生存率为71%,常规组为48%。3DCRT组放射性肺炎、放射性食管炎和血液反应率为21%、30%和71%,均略低于常规组。结论三维适形放疗可提高患者生存率,减轻放疗的毒副作用,治疗非小细胞肺癌比较有效。
Objective To investigate the results and toxic effect of three-dimensional conformal radiotherapy(3DCRT) for non-small-cell lung cancer. Methods 112 cases with stage III non-small-cell lung cancer were randomly divided into two groups; 56 in 3DRCT group and 56 in conventional group. In treatment group, patients were fractionated 3DRCT every other day and 4 - 8Gy every time. Total dosage were 40 - 70Gy.Results In 3DRCT group, the overall response rate was 67.8%(CR+PR)and complete remission rate was 32.1%(CR) while conventional group was 28.6% and 3.6%. respectively 3DRCT group was higher(P〈 0.05).Conclusion Three-dimensional conformal radiotherapy can increase the survival rate of patients and ease the toxic effect of chemotherapy. In a word, it' s an effective way to treat non- small-cell lung cancer.
出处
《国际医药卫生导报》
2012年第2期211-213,共3页
International Medicine and Health Guidance News
关键词
适形放疗
非小细胞癌
Conformal radiotherapy
Non-small-cell lung cancer